Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma cruzi | 13 | 2023 | 154 | 1.250 |
Why?
|
| Chagas Disease | 7 | 2023 | 101 | 0.730 |
Why?
|
| Proteome | 4 | 2024 | 150 | 0.630 |
Why?
|
| Protozoan Proteins | 7 | 2021 | 196 | 0.530 |
Why?
|
| Thrombospondin 1 | 3 | 2022 | 23 | 0.440 |
Why?
|
| RNA, Small Interfering | 4 | 2021 | 436 | 0.430 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 1679 | 0.420 |
Why?
|
| Proteomics | 6 | 2024 | 363 | 0.410 |
Why?
|
| Genomics | 3 | 2023 | 289 | 0.370 |
Why?
|
| Semen | 2 | 2021 | 55 | 0.330 |
Why?
|
| Trypanosoma brucei brucei | 2 | 2021 | 82 | 0.310 |
Why?
|
| Exosomes | 3 | 2019 | 124 | 0.290 |
Why?
|
| Porphyromonas gingivalis | 3 | 2024 | 39 | 0.270 |
Why?
|
| Humans | 36 | 2024 | 42163 | 0.250 |
Why?
|
| Electronic Health Records | 2 | 2024 | 99 | 0.250 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2024 | 9 | 0.250 |
Why?
|
| Benzo(a)pyrene | 2 | 2021 | 128 | 0.240 |
Why?
|
| Cocaine | 2 | 2021 | 248 | 0.240 |
Why?
|
| Monocytes | 2 | 2021 | 275 | 0.230 |
Why?
|
| Epithelial Cells | 3 | 2018 | 426 | 0.210 |
Why?
|
| Dental Plaque | 1 | 2024 | 13 | 0.210 |
Why?
|
| Streptococcus | 1 | 2024 | 18 | 0.210 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2022 | 60 | 0.210 |
Why?
|
| Periodontitis | 1 | 2024 | 56 | 0.200 |
Why?
|
| Protein Folding | 1 | 2024 | 123 | 0.200 |
Why?
|
| HIV Infections | 4 | 2021 | 2535 | 0.200 |
Why?
|
| Protein Conformation | 1 | 2024 | 420 | 0.190 |
Why?
|
| Gastritis | 1 | 2022 | 13 | 0.190 |
Why?
|
| Pancreatitis | 1 | 2022 | 21 | 0.190 |
Why?
|
| Medical Informatics | 1 | 2022 | 24 | 0.190 |
Why?
|
| Hypercalcemia | 1 | 2022 | 13 | 0.190 |
Why?
|
| Trypanosomiasis, African | 1 | 2021 | 22 | 0.180 |
Why?
|
| Chemotaxis | 1 | 2021 | 66 | 0.180 |
Why?
|
| HIV-1 | 2 | 2019 | 747 | 0.180 |
Why?
|
| Metformin | 1 | 2022 | 74 | 0.180 |
Why?
|
| Prostatic Neoplasms | 3 | 2022 | 1068 | 0.180 |
Why?
|
| beta Catenin | 1 | 2022 | 75 | 0.180 |
Why?
|
| Genome | 1 | 2022 | 149 | 0.170 |
Why?
|
| Gene Regulatory Networks | 4 | 2021 | 143 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2022 | 324 | 0.170 |
Why?
|
| Myoblasts | 1 | 2020 | 30 | 0.170 |
Why?
|
| Obstetric Labor, Premature | 2 | 2010 | 9 | 0.160 |
Why?
|
| Cell Cycle | 1 | 2021 | 348 | 0.160 |
Why?
|
| Blood | 1 | 2019 | 37 | 0.160 |
Why?
|
| Hepatitis C, Chronic | 1 | 2019 | 44 | 0.150 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2019 | 47 | 0.150 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2019 | 128 | 0.150 |
Why?
|
| RNA, Messenger | 5 | 2022 | 1265 | 0.140 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 223 | 0.140 |
Why?
|
| Female | 13 | 2024 | 24018 | 0.140 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 173 | 0.140 |
Why?
|
| Myocardium | 1 | 2020 | 251 | 0.140 |
Why?
|
| Homeostasis | 1 | 2019 | 193 | 0.140 |
Why?
|
| Colon | 1 | 2018 | 118 | 0.140 |
Why?
|
| Cell Nucleus | 2 | 2016 | 383 | 0.130 |
Why?
|
| Mouth | 1 | 2017 | 49 | 0.130 |
Why?
|
| Phosphoproteins | 1 | 2018 | 201 | 0.130 |
Why?
|
| Periodontal Diseases | 1 | 2017 | 49 | 0.130 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2016 | 6 | 0.130 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2016 | 11 | 0.130 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2016 | 8 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 683 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2021 | 501 | 0.120 |
Why?
|
| Transport Vesicles | 1 | 2014 | 22 | 0.110 |
Why?
|
| Variant Surface Glycoproteins, Trypanosoma | 1 | 2014 | 8 | 0.110 |
Why?
|
| Fimbriae, Bacterial | 1 | 2014 | 26 | 0.110 |
Why?
|
| Adenoviridae | 1 | 2014 | 62 | 0.110 |
Why?
|
| Virus Integration | 1 | 2015 | 65 | 0.110 |
Why?
|
| Phosphorus-Oxygen Lyases | 1 | 2014 | 7 | 0.110 |
Why?
|
| Mice | 8 | 2022 | 6490 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2017 | 381 | 0.110 |
Why?
|
| Animals | 12 | 2022 | 16695 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2014 | 165 | 0.110 |
Why?
|
| Capsid Proteins | 1 | 2014 | 74 | 0.110 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2014 | 49 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 933 | 0.100 |
Why?
|
| Cell Membrane | 2 | 2013 | 400 | 0.100 |
Why?
|
| alpha-Defensins | 1 | 2013 | 22 | 0.100 |
Why?
|
| Male | 10 | 2024 | 22779 | 0.100 |
Why?
|
| Flagella | 1 | 2013 | 31 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 276 | 0.100 |
Why?
|
| Locomotion | 1 | 2013 | 104 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 2598 | 0.100 |
Why?
|
| Calreticulin | 1 | 2012 | 8 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 133 | 0.100 |
Why?
|
| Cell Adhesion | 2 | 2012 | 237 | 0.090 |
Why?
|
| Models, Biological | 3 | 2018 | 711 | 0.090 |
Why?
|
| Cytidine Deaminase | 1 | 2011 | 36 | 0.090 |
Why?
|
| Fetus | 1 | 2012 | 101 | 0.090 |
Why?
|
| Heart | 2 | 2023 | 181 | 0.090 |
Why?
|
| Cardiovascular Diseases | 2 | 2021 | 729 | 0.080 |
Why?
|
| Prostate | 1 | 2011 | 152 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2012 | 318 | 0.080 |
Why?
|
| Acinetobacter Infections | 1 | 2010 | 24 | 0.080 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2010 | 34 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 64 | 0.080 |
Why?
|
| Acinetobacter baumannii | 1 | 2010 | 35 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2021 | 973 | 0.080 |
Why?
|
| Cross Infection | 1 | 2010 | 47 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2024 | 727 | 0.080 |
Why?
|
| Coronary Vessels | 1 | 2010 | 92 | 0.080 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2010 | 92 | 0.080 |
Why?
|
| RNA Interference | 2 | 2010 | 246 | 0.080 |
Why?
|
| Leukocytes | 1 | 2009 | 79 | 0.070 |
Why?
|
| Rats | 4 | 2022 | 3701 | 0.070 |
Why?
|
| Young Adult | 4 | 2021 | 4936 | 0.070 |
Why?
|
| Neoplasms | 2 | 2021 | 1341 | 0.060 |
Why?
|
| Myoblasts, Cardiac | 1 | 2006 | 4 | 0.060 |
Why?
|
| Mitochondria | 2 | 2021 | 516 | 0.060 |
Why?
|
| Casein Kinase II | 1 | 2006 | 16 | 0.060 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 228 | 0.060 |
Why?
|
| Viral Load | 2 | 2019 | 344 | 0.060 |
Why?
|
| Laminin | 1 | 2006 | 58 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2006 | 154 | 0.060 |
Why?
|
| Medical History Taking | 1 | 2024 | 37 | 0.060 |
Why?
|
| Fimbriae Proteins | 2 | 2014 | 21 | 0.060 |
Why?
|
| Neuraminidase | 2 | 2006 | 9 | 0.050 |
Why?
|
| Cell Line | 2 | 2021 | 1416 | 0.050 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2024 | 52 | 0.050 |
Why?
|
| Nitrogen | 1 | 2005 | 83 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2020 | 2111 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2005 | 199 | 0.050 |
Why?
|
| Middle Aged | 4 | 2021 | 11819 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1066 | 0.050 |
Why?
|
| Gene Expression | 3 | 2011 | 692 | 0.050 |
Why?
|
| Disease Progression | 2 | 2016 | 661 | 0.050 |
Why?
|
| Castration | 1 | 2022 | 34 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 249 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 1617 | 0.050 |
Why?
|
| Gender Identity | 1 | 2023 | 117 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2006 | 548 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 686 | 0.050 |
Why?
|
| Genetic Counseling | 1 | 2022 | 13 | 0.050 |
Why?
|
| Adult | 4 | 2021 | 13458 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 156 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 28 | 0.050 |
Why?
|
| Androgens | 1 | 2022 | 107 | 0.050 |
Why?
|
| Disclosure | 1 | 2022 | 36 | 0.050 |
Why?
|
| DNA, Kinetoplast | 1 | 2021 | 4 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 74 | 0.050 |
Why?
|
| Population Groups | 1 | 2022 | 59 | 0.050 |
Why?
|
| Genome, Human | 1 | 2022 | 143 | 0.040 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 144 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 77 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2024 | 845 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 310 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 7982 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 278 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 214 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 242 | 0.040 |
Why?
|
| Pregnancy | 3 | 2012 | 1737 | 0.040 |
Why?
|
| Cell Movement | 2 | 2016 | 640 | 0.040 |
Why?
|
| Communicable Diseases | 1 | 2021 | 47 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1112 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 54 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 2803 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 233 | 0.040 |
Why?
|
| Research Design | 1 | 2022 | 370 | 0.040 |
Why?
|
| Base Sequence | 1 | 2021 | 997 | 0.040 |
Why?
|
| Tennessee | 1 | 2019 | 88 | 0.040 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 14 | 0.040 |
Why?
|
| Adolescent | 2 | 2021 | 5950 | 0.040 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 65 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2020 | 190 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 725 | 0.040 |
Why?
|
| Calcium | 1 | 2022 | 487 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2019 | 2485 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 206 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2022 | 1010 | 0.040 |
Why?
|
| Glycoproteins | 1 | 1999 | 127 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 124 | 0.040 |
Why?
|
| DNA Damage | 1 | 2021 | 358 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2019 | 138 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 512 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2014 | 1804 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 239 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2019 | 317 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2019 | 189 | 0.030 |
Why?
|
| Gastrointestinal Motility | 1 | 2017 | 20 | 0.030 |
Why?
|
| Risk Factors | 2 | 2019 | 3942 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 557 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 51 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 1188 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 1559 | 0.030 |
Why?
|
| Saliva | 1 | 2017 | 115 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 102 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2016 | 129 | 0.030 |
Why?
|
| Biofilms | 1 | 2017 | 178 | 0.030 |
Why?
|
| Vesiculovirus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Phytohemagglutinins | 1 | 2015 | 15 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 166 | 0.030 |
Why?
|
| Proviruses | 1 | 2015 | 35 | 0.030 |
Why?
|
| Macrophages | 1 | 1999 | 515 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 73 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1420 | 0.030 |
Why?
|
| Ligands | 2 | 2010 | 387 | 0.030 |
Why?
|
| Endocytosis | 1 | 2015 | 117 | 0.030 |
Why?
|
| Cocaine-Related Disorders | 1 | 2015 | 99 | 0.030 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 40 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 244 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 295 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2013 | 40 | 0.030 |
Why?
|
| Virulence | 1 | 2014 | 238 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 167 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 990 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2015 | 323 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 506 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2010 | 534 | 0.020 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 168 | 0.020 |
Why?
|
| Plasminogen | 1 | 2012 | 10 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 649 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2012 | 30 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 128 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 106 | 0.020 |
Why?
|
| Systole | 1 | 2012 | 67 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 661 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 108 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 74 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 324 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 198 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 284 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 68 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 42 | 0.020 |
Why?
|
| Uterus | 1 | 2010 | 57 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 47 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 279 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 428 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2011 | 203 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2012 | 188 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 452 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 76 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 232 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 884 | 0.020 |
Why?
|
| Virus Replication | 1 | 2011 | 318 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 487 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 1169 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1076 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2009 | 75 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 160 | 0.020 |
Why?
|
| Urban Population | 1 | 2010 | 364 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 438 | 0.020 |
Why?
|
| Premature Birth | 1 | 2009 | 94 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 602 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 189 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 599 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 230 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 415 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 502 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2006 | 168 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2006 | 217 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2006 | 74 | 0.010 |
Why?
|
| Virulence Factors | 1 | 2006 | 119 | 0.010 |
Why?
|
| Prions | 1 | 2005 | 23 | 0.010 |
Why?
|
| Mathematics | 1 | 2005 | 57 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2005 | 90 | 0.010 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 100 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 110 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2005 | 267 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 3077 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 722 | 0.010 |
Why?
|
| Maleimides | 1 | 1999 | 12 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 51 | 0.010 |
Why?
|
| Cytosol | 1 | 1999 | 98 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 462 | 0.010 |
Why?
|
| Indoles | 1 | 1999 | 178 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 301 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 457 | 0.010 |
Why?
|